Company Data

Clene Inc.

Ticker
CLNN
Current Price
$3.59 -4.52%
Market Cap
$32.2M
Price Target
Refer to Report
Volume
75.0K
52wk Range
$2.2801 - $6.96
Advanced Market Data

Overview

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements).

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy